POET Applied sciences Declares Public Providing of Widespread Shares and Warrants

Article content material

TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) — POET Applied sciences Inc. (“POET” or the “Firm”) (TSX Enterprise: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic Built-in Circuits (PICs) for the info heart, telecommunication and synthetic intelligence markets, immediately introduced it has commenced an underwritten public providing in the USA (the “U.S. Providing”). Concurrently, the Firm has additionally commenced a non-brokered providing in Canada (the “LIFE Providing” and, along with the U.S. Providing, the “Providing”). The Providing consists of frequent shares of the Firm and warrants to buy frequent shares and is topic to market circumstances. There could be no assurance as as to whether or when the Providing could also be accomplished, or as to the precise measurement, pricing or different phrases of the Providing. As well as, POET intends to grant the underwriter a 45-day choice to buy as much as a further 15 % of the variety of frequent shares and/or warrants provided within the U.S. Providing.

Article content material

Maxim Group LLC is performing as sole book-running supervisor for the U.S. Providing.

Article content material

POET presently intends to make use of the web proceeds from the Providing, if accomplished, for normal working capital functions, together with income enlargement and the event and manufacturing of photonic modules for AI and associated markets.

The U.S. Providing is being made pursuant to an efficient shelf registration assertion on Type F-3 (File No. 333-273853) beforehand filed with the U.S. Securities and Trade Fee (the “SEC”) on August 9, 2023 and declared efficient on August 18, 2023. The securities within the U.S. Providing could also be provided in the USA solely by the use of a prospectus. A preliminary prospectus complement and the accompanying prospectus regarding and describing the phrases of the U.S. Providing will likely be filed with the SEC, will kind part of the efficient registration assertion and will likely be accessible on the SEC’s web site at www.sec.gov. When accessible, copies of the preliminary prospectus complement and accompanying prospectus regarding the U.S. Providing might also be obtained by contacting Maxim Group LLC at 300 Park Avenue, sixteenth Ground, New York, NY 10022, Consideration: Syndicate Division, by phone at (212) 895-3745 or by e mail at syndicate@maximgrp.com. Earlier than you make investments, you must learn the preliminary prospectus complement and accompanying prospectus and the opposite paperwork that POET has filed with the SEC for extra full details about POET and the U.S. Providing.

Article content material

Article content material

The LIFE Providing has been structured to benefit from the listed issuer financing exemption from prospectus necessities (the “Exemption”) in Half 5A of Nationwide Instrument 45-106 – Prospectus Exemptions (“NI 45-106”), whereby securities issued pursuant to the Exemption are freely tradeable listed fairness securities not topic to any maintain interval (see under). The LIFE Providing will likely be performed in all of the provinces of Canada, besides Québec, beneath the Exemption, for mixture gross proceeds as much as C$10,000,000. There may be an providing doc regarding the LIFE Providing (the “Providing Doc”) that may be accessed beneath the Firm’s profile on SEDAR+ at www.sedar.com and on the Firm’s web site www.poet-technologies.com. Potential buyers within the LIFE Providing ought to learn the Providing Doc earlier than investing resolution.   The securities being provided within the LIFE Providing haven’t been registered beneath the USA Securities Act of 1933, as amended (the “U.S. Securities Act”), and such securities is probably not provided or bought inside the USA besides pursuant to an efficient registration assertion in the USA or an exemption from the registration necessities of the U.S. Securities Act and relevant state securities legal guidelines.

Article content material

This press launch doesn’t represent a proposal to promote or the solicitation of a proposal to purchase these securities, nor shall there be any sale of those securities in any state or different jurisdiction wherein such provide, solicitation or sale can be illegal previous to the registration or qualification beneath the securities legal guidelines of any such state or different jurisdiction.

About POET Applied sciences Inc.
POET Applied sciences is a design and growth firm providing integration options based mostly on the POET Optical Interposer™, a novel platform that permits the seamless integration of digital and photonic units right into a single multi-chip module utilizing superior wafer-level semiconductor manufacturing methods and packaging strategies. POET’s Optical Interposer eliminates expensive parts and labor-intensive meeting, alignment, burn-in and testing strategies employed in standard photonics. The associated fee-efficient integration scheme and scalability of the POET Optical Interposer brings worth to any gadget or system that integrates electronics and photonics, together with a few of the highest development areas of computing, reminiscent of Synthetic Intelligence (AI), the Web of Issues (IoT), autonomous automobiles and high-speed networking for cloud service suppliers and knowledge facilities. POET is headquartered in Toronto, with operations in Allentown, PA, Shenzhen, China and Singapore. Extra data could also be obtained at www.poet-technologies.com.

Article content material

Ahead-Trying Statements
This press launch incorporates “forward-looking data” (throughout the which means of relevant Canadian securities legal guidelines) and “forward-looking statements” (throughout the which means of the U.S. Non-public Securities Litigation Reform Act of 1995). Such statements or data are recognized with phrases reminiscent of “anticipate”, “consider”, “anticipate”, “plan”, “intend”, “potential”, “estimate”, “suggest”, “mission”, “outlook”, “foresee” or comparable phrases suggesting future outcomes or statements relating to an outlook. Such data and statements embrace the Firm’s anticipated use of the web proceeds of the general public providing (if any).

Such forward-looking data or statements are based mostly on numerous dangers, uncertainties and assumptions which can trigger precise outcomes or different expectations to vary materially from these anticipated and which can show to be incorrect. Assumptions have been made relating to, amongst different issues, the Firm’s capacity to finish the Providing within the method described, or in any respect, the receipt of all required regulatory approvals with respect to the Providing, administration’s expectations relating to the success of the Firm’s introduced merchandise, the timing of completion of its growth efforts, the profitable implementation of its optical engine or mild supply merchandise, the success of its clients’ merchandise, the capabilities of its operations, together with its three way partnership, the Firm’s capacity to appropriately gauge market wants and to provide merchandise within the required quantities and on a well timed foundation. Precise outcomes might differ materially attributable to numerous elements, together with, with out limitation, delays or modifications of plan with respect to the Providing described herein, termination of the Providing in accordance with its phrases, the dilutive results of the Providing, market circumstances, the failure of the Firm’s merchandise to satisfy efficiency necessities, the failure to provide merchandise on a well timed foundation or in any respect, the failure of the Firm’s optical engine or mild supply merchandise to be integrated into its clients’ merchandise, the failure of its clients’ merchandise to realize market penetration, operational dangers together with the power to draw key personnel, and the Firm’s capacity to lift further capital if mandatory. Though the Firm believes that the expectations mirrored within the forward-looking data or statements are affordable, potential buyers within the Firm’s securities shouldn’t place undue reliance on forward-looking data and statements as a result of the Firm can present no assurance that such expectations will show to be appropriate. Ahead-looking data and statements contained on this press launch are as of the date of this press launch and the Firm assumes no obligation to replace or revise this forward-looking data and statements besides as required by regulation.

Contacts:

Neither TSX Enterprise Trade nor its Regulation Providers Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Trade) accepts accountability for the adequacy or accuracy of this launch.
120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 – Fax: 416-322-507

Article content material